How long should a patient hold opiates (opioid analgesics) before a Hida scan and do they need to be NPO (nothing by mouth)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIDA Scan Preparation: Opioid Hold and NPO Requirements

Patients requiring a HIDA scan must hold opiates for at least 48 hours before testing and should be NPO for 4-6 hours minimum (optimally overnight fast) prior to the study. 1

Opioid Withholding Requirements

The 48-hour opioid hold is critical to prevent false-positive results. Opiates and their metabolites cause sphincter of Oddi spasm and decrease gallbladder ejection fraction, which can spuriously reduce GBEF values and lead to misdiagnosis of gallbladder dysfunction. 1, 2

Mechanism of Interference

  • Opioid drugs cause marked bile duct obstruction by inducing biliary sphincter spasm, which delays clearance of the radiotracer from the common bile duct and can simulate pathological obstruction. 3
  • Morphine and other opiate metabolites circulate in blood for many hours and directly act on the sphincter of Oddi while simultaneously decreasing gallbladder ejection fraction. 2
  • A careful drug history, especially regarding opiates, is critical in all patients before performing HIDA scan to avoid assigning false abnormality to gallbladder motor function. 2

Additional Medications to Hold

  • Anticholinergic drugs should also be withheld for at least 48 hours before testing. 1
  • Other medications affecting gallbladder contraction must be held for 24 hours prior to the study, including: nifedipine, indomethacin, octreotide, theophylline, benzodiazepines, phentolamine, isoproterenol, and progesterone. 1
  • Nicotine and alcohol should be avoided prior to testing as they may affect gallbladder contraction. 1

NPO Requirements

Patients should optimally fast from the evening before the study, or at minimum 4-6 hours prior to the study. 1

Rationale for Fasting

  • Proper patient preparation with adequate fasting is essential to avoid false-positive results. 1
  • The gallbladder must be in a fasted state to allow proper filling with the radiotracer during the initial imaging phase. 1
  • If the gallbladder has not filled by 60 minutes in a properly prepared patient, the finding is reported as abnormal, potentially consistent with either acute or chronic cholecystitis depending on clinical presentation. 1

Critical Clinical Context

CCK-cholescintigraphy should be performed on an outpatient basis, not while the patient is hospitalized or acutely ill. 1

Common Pitfalls to Avoid

  • Many confounding factors in acutely ill hospitalized patients can spuriously decrease GBEF, including the illness itself and therapeutic medications (particularly opioids). 1
  • Administering opioids within several hours before a diagnostic hepatobiliary scan can lead to delayed clearance of radiotracer from the common bile duct, potentially resulting in an erroneous diagnosis and indicating a potentially unnecessary common bile duct exploration. 3
  • The 24-hour abstinence from opioids recommended in some bariatric surgery protocols may be insufficient; the 48-hour guideline from consensus recommendations should be followed. 4

Contraindications

  • Known allergic reaction to sincalide (CCK analog used during the study). 1
  • Intestinal obstruction. 1
  • Pregnancy (sincalide use is contraindicated as it may stimulate preterm labor, though the Tc-99m HIDA radiotracer itself is generally considered safe). 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.